Clinical Trial for Prostate Cancer

• Status: Completed
• Trial end date: 1969-12-31
• Target enrollment: 0
• Participant gender: Male

Summary

Phase III trial using an injectable for treatment of prostate cancer.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Oakwood Laboratories, LLC
• Treatments: Leuprolide